Skip to main content

Policy papers and consultations

Skip to results
1,954 results sorted by Updated (newest)
About Health and social care
  • This consultation collected views on expanding the use of naloxone. It ran for 8 weeks and was open to all interested individuals and organisations.

    First published during the 2019 to 2022 Johnson Conservative government

  • We want to find out what skills and experience you think are important for adult social care staff.

    First published during the 2022 to 2024 Sunak Conservative government

  • We want your views on what should be included within a new care workforce pathway for adult social care.

    First published during the 2022 to 2024 Sunak Conservative government

  • The Advisory Council on the Misuse of Drugs (ACMD) seeks to gather insight into current government-led drug prevention policies and landscape across the UK.

    First published during the 2022 to 2024 Sunak Conservative government

  • UK NSC consulted on whether providers can safely use digital pathology as an alternative to light microscopy in examination of NHS cancer screening samples.

  • This is a consultation on a statutory instrument to amend the Human Medicines Regulations 2012 to remove the provision which provides the legal basis to the European Commission Decision Reliance Procedure (ECDRP).

  • This consultation will inform the government's proposed development of secondary legislation on visiting in care homes, hospitals and hospices.

    First published during the 2022 to 2024 Sunak Conservative government

  • The Advisory Council on the Misuse of Drugs call for evidence, collecting written evidence to better understand internet-facilitated drug markets (IFDMs).

    First published during the 2022 to 2024 Sunak Conservative government

  • Seeks views on the proposal to remove the statutory requirement for a full employment history when appointing volunteers in health and care settings.

    First published during the 2022 to 2024 Sunak Conservative government

  • A review that examines the risks of modern slavery within NHS supply chains and provides recommendations to mitigate these risks.

    First published during the 2022 to 2024 Sunak Conservative government

  • An agreement between DHSC, NHS England and ABPI to support patient access to medicines, the financial sustainability of the NHS and the UK life sciences sector.

    First published during the 2022 to 2024 Sunak Conservative government

  • We want your views on the revision of 13 existing EALs.

  • The MHRA is reviewing its approach to engagement with healthcare professionals to improve the safety of medicines and medical devices.

  • The full government response to the Lord O'Shaughnessy independent review of UK commercial clinical trials.

    First published during the 2022 to 2024 Sunak Conservative government

  • DHSC is seeking views on proposals to modernise legislation governing the supervision of activities by a pharmacist in a pharmacy.

    First published during the 2022 to 2024 Sunak Conservative government

  • This consultation seeks views on proposals for introducing coronial investigations of stillbirth cases in England and Wales.

    First published during the 2016 to 2019 May Conservative government

  • The government wants to make some new rules on visiting care homes, hospitals and hospices in England. We would like your ideas.

    First published during the 2022 to 2024 Sunak Conservative government

  • This consultation considers the proposed review of the statutory scheme to control the cost of branded health service medicines.

    First published during the 2022 to 2024 Sunak Conservative government

  • Setting out the department's priorities for innovation and scaling in adult social care, including identifying, recognising and supporting unpaid carers.

    First published during the 2022 to 2024 Sunak Conservative government

  • This consultation invites feedback on the draft updated National Radon Action Plan (NRAP), which addresses the health risks from public exposure to radon.